Vermillion Files Plan of Reorganization
Vermillion Inc has announced the Company filed its Plan of Reorganization and Disclosure Statement today, November 24, 2009, with the United States Bankruptcy Court for the District of Delaware.
Read MoreMonth: November 2009
Prodesse’s ProParaflu+ Assay Cleared for US Marketing by FDA
Gen-Probe Inc has announced that the FDA has cleared for marketing Prodesse’s ProParaflu+ assay, a molecular test that detects and differentiates parainfluenza 1, 2 and 3 viruses, which cause lower respiratory tract infections.
Read MoreNew Hair Data Validate Downward Trend in Cocaine, Methamphetamine
New data released today by Quest Diagnostics Inc reveal that drug testing of hair specimens from employees and job applicants in the general US workforce has tracked sharp downward trends in cocaine and methamphetamine use from 2005 to the first half of 2009 that mirror similar drops shown by urine testing.
Read MoreBD Completes Acquisition of HandyLab Inc
BD (Becton, Dickinson and Company) announced the completion of its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms.
Read MoreHHS Plans to Make $80 Million Available to Support Health IT Workforce
Dr David Blumenthal, HHS National Coordinator for Health Information Technology, announced plans to make available $80 million in grants to help develop and strengthen the health information technology workforce.
Read More